Effects by Omission of Bandage Over Exit Site

NCT ID: NCT02102425

Last Updated: 2016-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-31

Study Completion Date

2017-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Peritoneal dialysis, known as p- dialysis (PD), is a dialysis form in which the blood is purified by using the body's peritoneum. PD dependents on good access to peritoneum. For this, a catheter is implanted in the peritoneum and tunneled 2-3 cm below the skin. The way out is called exit site and is close to the navel.

Patients are selected at random to use bandage or not use bandage for three months, then cross-over. The overall objective of the research is that the patient in PD maintains a complete and healthy skin without signs of infection around the exit site. In the study effects by omission of bandage over exit site at patients in PD are examined when the patients are in a stable process with PD. The patient's exit site is assessed according to skin character and examined for infection.

The hypothesis is that there is no greater rate of infection in patients without bandage than in patients with bandage over the exit site, and that patients without bandage will have stronger skin around exit site.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: For a patient in a stable (PD) there is no evidence for using bandage over exit site. Guidelines refer to this as an unsolved question.

An exit site infection can lead to tunnel infection and to peritonitis, which can be fatal. For this reason it is very important to prevent exit site infections and at the same time it is very important to reduce antibiotic which is a general problem in health care. (In Denmark, the patient does not use antibiotic cream around exit site, preventive.) Few years back, the care of the exit site was associated with sterile techniques, and the use of bandage was an obligatory procedure. The risk of infection appears now to be much less than first thought, but it is unclear what procedures are best: bandage or no bandage.

At present, most patients use bandage, but some patients drop it when bandage leads to maceration of the skin, allergy or wetness around the exit site. Other patients simply do not want to use bandage with subjective reasons. A dialysis catheter interferes with the patient's bodily life, integrity, autonomy and with the social sphere.

The nurses in the PD clinic at Aalborg University Hospital might have observed that patients without bandage do not get more infections around the exit site in relation to the patients using bandage. However, the study should develop evidence guidelines.

Objective: The aim of the study is to study the effects by omission of bandage over exit site at patient in PD when the patient is in a stable course. The purpose is that the patient maintains an unbroken skin without signs of infection around the exit site.

Design: Randomized controlled cross-over study. Setting: Department of outpatient clinic for peritoneal dialysis, Departments of Nephrology, Aalborg University Hospital in Region Northern Denmark.

Participants: The estimated numbers of participants are 35 men and women aged \> 18 years. The patients are in stable PD with uraemia chronic classified by International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD10) - kode DN189 - and will be enrolling and included by invitations in the outpatient clinic. Exclusion criteria: special reasons for protection of the exit site - eg. critical illness, stay in areas with high risk of infection or body movements that require special fixation of the exit site, do not understand or speak Danish, mental impairment or symptoms of eczema around the exit site.

Inclusion time: March 2014 to september 2015. Method: By inclusion patients are randomized to either use or not use bandage. After 3 months the patient will cross over and do the opposite.

By inclusion investigators collect data to baseline characteristics (age, sex, marital status, other diseases, smoking, height and weight, medication use, self-reliance, time of construction of p-catheter, type of catheter, who is caring for the exit site at home and how often is changing of bandage per. week, previous infections, skin itching). The nurse in the outpatient clinic also examines a bath instruction with the patient.

The primary endpoint is the condition of the skin around the exit site as measured by Sunnybrook PD Catheter Exit Site Assessment Tool prepared by Patsy Cho and colleagues. Following parameters are recorded: Redness, crust, swelling, pain, secretion. The patient is assessed a total of five times with this skin assessment: at inclusion, after 6 weeks, 3 months (cross-over), 4.5 months and 6 months.

At these four controls investigators also collect data on: Infection, self-reliance, who is caring for the exit site and how often is changing of bandage per. week, skin itching. Moreover, the patient must answer a questionnaire on compliance and experiences of wearing bandage or not wearing bandage.

All data entered in a database. Main outcome measures: The primary endpoint is the condition of the skin around the exit site. The secondary endpoints will partly be the number of exit site infections, tunnel infections and peritonitis and the third point is a record of patient compliance and experiences in relation to participation in the project.

The trial is approved by the local Ethics Committee, registration number: N-20130076

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Insufficiency, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic kidney disease, PD

Patients with or without bandage over exit site

Patients with or without bandage over exit site

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients with or without bandage over exit site

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with uraemia chronic classified by ICD10 kode DN189. The patients are in stable PD. Talk og understand Danish.

Exclusion Criteria

Special reasons for protection of the exit site (- eg. critical illness, stay in areas with high risk of infection or body movements that require special fixation of the exit site) Mental impairment.

Symptoms of eczema around the exit site.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aalborg University Hospital

OTHER

Sponsor Role collaborator

Edith Mark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Edith Mark

Postdoc in Clinical Nursing

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erik E Sørensen, PhD Nursing

Role: STUDY_CHAIR

Clinical Nursing Research Unit, Aalborg University Hospital, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PD-ambulatorium, Clinical Nursing Research Unit/Department of Nephrology, Aalborg University Hospital,

Aalborg, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Birgitte S Laursen, PhD

Role: CONTACT

+45 22 40 87 63

Erik E Sørensen, PhD

Role: CONTACT

+45 97 66 62 83

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lotte G Svendsen, Nurse

Role: primary

+ 45 97 66 37 72

Hanne Agnholt, MSc Nursing

Role: backup

+45 97 66 37 41

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N-20130076

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PD Catheter Data Collection
NCT07156123 NOT_YET_RECRUITING